Mediterranean Journal of Hematology and Infectious Diseases (Apr 2024)

Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era

  • Serena Vita,
  • Emanuela Giombini,
  • Patrizia De Marco,
  • Martina Rueca,
  • Cesare Ernesto Maria Gruber,
  • Alessia Beccacece,
  • Laura Scorzolini,
  • Valentina Mazzotta,
  • Carmen Pinnetti,
  • Priscilla Caputi,
  • Daniele Focosi,
  • Enrico Girardi,
  • Andrea Antinori,
  • Fabrizio Maggi,
  • Alessandra D'Abramo,
  • Emanuele Nicastri,
  • Investigation Team Spallanzani COVID-19 case

DOI
https://doi.org/10.4084/MJHID.2024.043
Journal volume & issue
Vol. 16, no. 1

Abstract

Read online

Abstract: Im We describe here a single-center case series of 27 IC COVID-19 inpatients (mostly with haematological disorders) treated with a combined therapy based on tixagevimab/cilgavimab (T/C) plus small-molecule antivirals (AV), between April 1 2022 and November 30 2022. Keywords: immunocompromised; SARS-CoV-2 infection; monoclonal antibodies; antivirals; persistent infection; viral evolution